logologo
QuantliQuantli

Nuvectis Pharma Inc

NVCT

NASDAQ

Biotechnology

$18.96

USD

-0.27 (-1.40%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $626.54M

Volume 106.7K

Price Target

$33.00$39.00

USD

The 2 analysts offering 1-year price forecasts have a max estimate of $39.00 and a min estimate of $33.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$36.00

Implied Upside

+89.9%

Analyst Covering

2

Consensus

Buy

Signal Quality

Consensus Freshness

100%

Most ratings are recent - from the last 3 months

Analyst Agreement

Moderate

Targets show moderate spread across analysts

Mean vs Median

$0 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

2 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

2

Hold

0

Sell

0

Strong Sell

0

2 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Jonathan Aschoff

Roth Capital

Buy

Maintained

1 month ago

Plus
Plus
Plus

Joseph Pantginis

HC Wainwright & Co.

Buy

Maintained

1 month ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

SGMT

Sagimet Biosciences Inc

$10.55

+13.7%

EIKN

Eikon Therapeutics Inc

$11.05

+7.0%

ARTV

Artiva Biotherapeutics Inc

$11.45

+1.3%

CBIO

Crescent Biopharma Inc

$17.14

+3.1%

FDMT

4D Molecular Therapeutics Inc

$12.19

+4.6%

PRME

Prime Medicine Inc

$3.09

-2.5%

MDXG

MiMedx Group Inc

$4.27

+1.7%

ALT

Altimmune Inc

$2.94

+2.1%

SPRY

ARS Pharmaceuticals Inc

$5.65

-7.4%

ASMB

Assembly Biosciences Inc

$32.95

+10.0%